After abdominal skin removal surgery, one chart review found delayed wound healing in 18.5% of GLP-1 users and 7.5% of nonusers. The study found fewer seromas, or fluid collections under the skin, among GLP-1 users (4.9% versus 14.0%).[1]
What the abdominal skin-removal study could measure
The review included 81 GLP-1 users and 292 nonusers who had a panniculectomy. It excluded patients with prior bariatric surgery or a hernia repair at the same time. More GLP-1 users had type 2 diabetes (55.6% versus 29.5%), as well as hypertension or chronic obstructive pulmonary disease. The review found no statistically clear differences in infection, hematoma, or fat necrosis. A chart review cannot establish that the medicine caused a difference in healing.[1]
Discuss your medication plan before surgery
Guidance on GLP-1 use before surgery or endoscopy considers why you take the medication, digestive symptoms, and the type of procedure and anesthesia. The American Society of Anesthesiologists says most patients can continue before a procedure, with individualized planning when risks are higher. Tell the surgical and anesthesia teams what you take and ask them to coordinate with your prescriber before you make changes.[3][4]
What a smaller semaglutide study found
A separate retrospective study compared four groups of 20 patients undergoing lipoabdominoplasty. Thirty-day complications occurred in nine patients who continued semaglutide up to surgery, six who stopped two weeks earlier, two who stopped four weeks earlier, and two who had never taken it. The outcome combined complications such as wound opening, infection, and seroma. Patients were not randomized to stopping times, and these small groups cannot establish which interval is safest.[2]